Supplemental material
Bioengineered
Volume 13, 2022 - Issue 1
Open access
1,431
Views
6
CrossRef citations to date
0
Altmetric
Research Paper
Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis
Lipeng Wanga Department of Dermatology, General Hospital of Ningxia Medical University, Yinchuan City, ChinaView further author information
, Shaozhang Houb Department of Pathology, School of Basic Medicine, Ningxia Medical University, Yinchuan City, China;c Ningxia Innovation Team of the Foundation and Clinical Researches of Diabetes and Its Complications, Yinchuan City, ChinaView further author information
, Jianning Lid Department of Biochemistry and Molecular Biology, School of Basic Medicine, Ningxia Medical University, Yinchuan City, ChinaView further author information
, Tian Tiana Department of Dermatology, General Hospital of Ningxia Medical University, Yinchuan City, ChinaView further author information
, Rongying Hua Department of Dermatology, General Hospital of Ningxia Medical University, Yinchuan City, ChinaView further author information
& Nan Yua Department of Dermatology, General Hospital of Ningxia Medical University, Yinchuan City, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-2946-6790View further author information
https://orcid.org/0000-0002-2946-6790View further author information
Pages 1209-1223
|
Received 17 Sep 2021, Accepted 12 Dec 2021, Published online: 04 Jan 2022
Related Research Data
Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.